Key Benefits & Uses

• Blood Sugar Control: Helps lower blood glucose levels in adults with type 2 diabetes when used alongside diet and exercise.

• Cardiovascular Protection: Reduces the risk of heart attack, stroke, and death from cardiovascular causes in individuals with type 2 diabetes and established heart disease.

• Kidney Health: Slows the progression of kidney disease and reduces the risk of end-stage kidney failure in patients with diabetic nephropathy.

• Weight Management: May aid in modest weight loss as a secondary benefit.

How to Use

• Dosage: Start with 100 mg once daily before the first meal. If well-tolerated and additional glycemic control is needed, the dose may be increased to 300 mg daily.

• Administration: Take the tablet whole with a glass of water.

• Missed Dose: If a dose is missed, take it as soon as remembered unless it’s almost time for the next dose. Do not double doses.

Important Safety Information

• Not for Type 1 Diabetes: Invokana is not approved for use in individuals with type 1 diabetes.

• Kidney Function: Not recommended for patients with severe kidney impairment (eGFR <30 mL/min/1.73 m²).

• Pregnancy & Breastfeeding: Consult your doctor before use if pregnant or breastfeeding.

• Drug Interactions: Inform your healthcare provider about all other medications you’re taking to avoid potential interactions.

Common Side Effects

• Genital fungal infections

• Urinary tract infections

• Increased urination

• Dehydration

• Dizziness

• Elevated potassium levels

• Bone fractures (with prolonged use)

For a comprehensive list of side effects, consult the FDA label.

Why Choose Invokana?

Invokana offers a multifaceted approach to managing type 2 diabetes. Its ability to control blood sugar levels, combined with benefits for heart and kidney health, makes it a valuable option for patients at risk of cardiovascular and renal complications. Unlike some other diabetes medications, Invokana works independently of insulin, providing an alternative for those who may not achieve adequate control with insulin alone.